E
Rocket Pharmaceuticals, Inc. RCKT
$3.39 -$0.15-4.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 1.04% 1.16% -1.12% -7.79% -6.00%
Total Depreciation and Amortization 8.77% 32.61% 22.02% 35.82% 36.97%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 39.26% -4.10% 80.80% 5.18% -19.97%
Change in Net Operating Assets 20.53% -0.64% -103.28% 147.58% 35.55%
Cash from Operations 9.03% 1.87% -60.00% 8.83% -5.81%
Capital Expenditure 97.41% 82.11% 93.35% 65.89% 53.14%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -44.73% -255.58% 72.41% 52.16% 62.93%
Cash from Investing -42.90% -265.65% 73.10% 63.55% 78.25%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- 46,664.45% -99.91% 740.66%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -85.95% -- 46,664.45% -99.91% 740.66%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -610.00% -451.53% 157.75% -85.05% 117.10%